Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Cellular Biomedicine Group, Inc. | Financial_Report.xls |
| EX-32.1 - CEO CERTIFICATION - Cellular Biomedicine Group, Inc. | ebig_ex321.htm |
| EX-31.1 - CEO CERTIFICATION - Cellular Biomedicine Group, Inc. | ebig_ex311.htm |
| EX-31.2 - CFO CERTIFICATION - Cellular Biomedicine Group, Inc. | ebig_ex312.htm |
| 10-Q - FORM 10-Q - Cellular Biomedicine Group, Inc. | ebig_10q.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of EastBridge Investment Group Corp. (the "Company") for the quarter ended March 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned Norm Klein, Chief Financial Officer of EastBridge Investment Group Corp., certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Dated: May 15, 2012
|
By:
|
/s/ Norman Klein | |
| Norman Klein | |||
| Chief Financial Officer | |||
| (Principal Financial and Accounting Officer) | |||